Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis

被引:0
|
作者
Julia Wälscher
Sabine Witt
Larissa Schwarzkopf
Michael Kreuter
机构
[1] University of Heidelberg,Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik
[2] Member of the German Center for Lung Research (DZL),undefined
[3] Institute of Health Economics and Health Care Management,undefined
[4] Helmholtz Zentrum München (GmbH) - German Research Center for Environmental Health,undefined
[5] Comprehensive Pneumology Center Munich (CPC-M),undefined
[6] Member of the German Center for Lung Research (DZL),undefined
来源
关键词
Interstitial lung disease; Hospitalisation; Comorbidity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
    Zhou, Zhou
    Fan, Yanni
    Thomason, Darren
    Tang, Wenxi
    Liu, Xinyue
    Zhou, Zheng-Yi
    Macaulay, Dendy
    Fischer, Aryeh
    ADVANCES IN THERAPY, 2019, 36 (05) : 1100 - 1113
  • [22] Patterns Of Healthcare Utilization By Patients With Interstitial Lung Disease
    Rodriguez, A.
    Nastase, A.
    Knox, K. S.
    Carr, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis
    Gauthier, Genevieve
    Levin, Rebecca
    Vekeman, Francis
    Manuel Reyes, Juan
    Chiarello, Esteban
    Ponce de Leon, Dario
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (12) : 2185 - 2196
  • [24] Assessing the lung cancer comorbidome: An analysis of German claims data
    Murawski, Monika
    Walter, Julia
    Schwarzkopf, Larissa
    LUNG CANCER, 2019, 127 : 122 - 129
  • [25] DISEASE CHARACTERIZATION AND TREATMENT PATTERNS OF PATIENTS WITH MYELOFIBROSIS: ANALYSIS OF US CLAIMS DATABASES
    Mehra, M.
    Wang, G.
    He, J.
    Bussolari, J.
    Desai, A.
    HAEMATOLOGICA, 2016, 101 : 808 - 808
  • [26] Contemporary chemotherapy treatment patterns in non-small cell lung cancer patients: An analysis of an Optum claims data
    Zhang, Dongmu
    Tyczynski, Jerzy E.
    Bach, Bruce A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 135 - 135
  • [27] Treatment sequences and time on specific treatments in patients with inflammatory bowel disease under advanced treatment - a German claims data analysis
    Dignass, A.
    Teich, N.
    Kudernatsch, R.
    Suenwoldt, J.
    Grellmann, C.
    Sende, F.
    Kaiser, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1861 - I1863
  • [28] SYMPTOMS AND COMORBIDITIES OF OLDER ADULT LUNG CANCER PATIENTS IN THE 2017 MEDICARE CLAIMS DATA
    Herrier, Noelle
    Griffith, Kathleen
    Ryan, Alice
    Hogans, Beth
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 55 - 55
  • [29] Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany
    Hernandez, Diego
    Cheng, Chih-yuan
    Hernandez-villafuerte, Karla
    Schlander, Michael
    ONCOLOGY RESEARCH, 2022, 30 (04) : 173 - 185
  • [30] BURDEN OF ILLNESS IN PATIENTS WITH PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE: A REAL-WORLD ANALYSIS USING US CLAIMS DATA
    Heresi, Gustavo
    Castillo, Howard
    Lee, Henry
    Classi, Peter
    Stafkey-Mailey, Dana
    Morland, Kellie
    Sketch, Margaret
    Kantorovich, Alexander
    Wu, Benjamin
    Dean, Bonnie
    CHEST, 2021, 160 (04) : 2322A - 2323A